Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
Stock Snapshot
With a market cap of 5.57B, Alkermes(ALKS) trades at $33.49. The stock has a price-to-earnings ratio of 23.90.
On 2026-04-22, Alkermes(ALKS) stock moved within a range of $33.33 to $33.79. With shares now at $33.49, the stock is trading +0.5% above its intraday low and -0.9% below the session's peak.
Trading activity shows a volume of 410.9K, compared to an average daily volume of 1.92M.
The stock's 52-week range extends from a low of $25.17 to a high of $36.48.
The stock's 52-week range extends from a low of $25.17 to a high of $36.48.
ALKS News
Needham analyst Ami Fadia maintained a Buy rating on Alkermes today and set a price target of $45.00. Claim 30% Off TipRanks Unlock hedge fund-level data and po...
Alkermes (ALKS) announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 at the American...
Analyst ratings
82%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.